<code id='D8160B8000'></code><style id='D8160B8000'></style>

<acronym id='D8160B8000'></acronym>

<center id='D8160B8000'><center id='D8160B8000'><tfoot id='D8160B8000'></tfoot></center><abbr id='D8160B8000'><dir id='D8160B8000'><tfoot id='D8160B8000'></tfoot><noframes id='D8160B8000'>

<optgroup id='D8160B8000'><strike id='D8160B8000'><sup id='D8160B8000'></sup></strike><code id='D8160B8000'></code></optgroup>

<b id='D8160B8000'><label id='D8160B8000'><select id='D8160B8000'><dt id='D8160B8000'><span id='D8160B8000'></span></dt></select></label></b><u id='D8160B8000'></u>

~~<i id='D8160B8000'><strike id='D8160B8000'><tt id='D8160B8000'><pre id='D8160B8000'></pre></tt></strike></i>~~

Home» leisure time» leisure time

leisure time

leisure time

author：comprehensive 2025-10-04 06:43:17 Page View：2969

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

advertisement

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cosmetics set for new safety regulation. Why the industry is on board
Next article： Medicare details structure of new drug price negotiation program

comprehensive

Medicare proposal to cover medical devices draws a mixed reaction

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

Doctors find melanoma drugs effective against rare brain cancer

Doctors find melanoma drugs effective against rare brain cancer

Micrographofpapillarycraniopharyngeoma,inthebrain.Sarahkayb/WikimediaCommonsBygoingdowntothemolecula

Activists slam private health insurers over coverage restrictions

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Key House panel plots a new health care package

CommitteechairmanRep.JasonSmith(R-Mo.)speakswithrankingmemberRep.RichardNeal(D-Mass.).DrewAngerer/Ge

read more